The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

NCT05680870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy Induced Peripheral Neuropathy

Interventions

DRUG: Omeprazole

Sponsor

Aya Mohamed Sadek Elsaid